Johns Hopkins University, $20,000
Gastric bypass surgery leads to the remission of type II diabetes in up to 98% of patients, but it is invasive. By using key insights from surgery, this team is developing a less invasive method that modulates the GI tract and leads to improvements in blood glucose control and reduces long term complications of the disease.